DSS, Inc.
DSSDSS, Inc. is a technology company specializing in advanced 3D imaging and electronic design automation solutions. It provides products and services primarily for defense, aerospace, and industrial applications, focusing on high-performance visualization, imaging, and electronic component design and testing.
Company News
DSS, Inc. announced that its subsidiary, Impact BioMedical Inc., has entered into a definitive merger agreement with Dr. Ashleys Limited, a global pharmaceutical company. The transaction will result in a newly formed combined entity traded on the NYSE American under the name 'Dr Ashleys Limited'.
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Compos...
Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024. DouYu International shares jumped 14.2% to $0.8320 ...
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock spl...
